Allscripts (MDRX) Misses Q1 EPS by 1c, Lowers FY15 Revenue Guidance

Allscripts (NASDAQ: MDRX) reported Q1 EPS of $0.08, $0.01 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $335 million versus the consensus estimate of $344.73 million. Bookings in the first quarter of 2015 were a record $236 million compared with $223 million in the first quarter of 2014, a 6 percent increase

Allscripts sees FY2015 revenue of $1.40-1.43 billion, versus prior guidance of $4.43-1.46 billion and the consensus of $1.43 billion. Allscripts is confirming its full year Adjusted EBITDA and non-GAAP earnings per diluted share that the Company introduced earlier this year.

For earnings history and earnings-related data on Allscripts (MDRX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Wintermar acquires full control of Fast Offshore Supply, adding 5 new CTVs
• Jefferies Reinstates Talen Energy (TLN) at Hold